zilongwang/ReadingBank huggingface dataset:
Equality monitoring In order to ensure that we provide the right services and that we avoid discriminating against any section of our community, it is important for us to gather the following information. No personal information will be released when reporting statistical data and data will be protected and stored securely in line with data protection rules. This information will be kept confidential. 1. What sex are you? Male Female Prefer not to say 2. How old are you? Prefer not to say 3. Which country were you born in? Prefer not to say 4. Do you belong to any religion? Buddhism Christianity Hinduism Islam Judaism Sikhism No religion Other (Please specify in the box below) Prefer not to say 5. What is your ethnic group? Asian or Asian British: Indian Pakistani Bangladeshi Chinese Other Asian background (please specify) Black or Black British: Caribbean African Other Black background (please specify) Mixed or multiple ethnic groups: White and Black Caribbean White and Black African White and Asian Other mixed background (please specify) White: English/Welsh/Scottish/Northern Irish/British Irish Gypsy or Irish Traveller Other White background (please specify) Other ethnic groups: Arab Any other ethnic group (please specify) Prefer not to say
HL3H 04 PPL1FOH8 Prepare, Service and Clear Meeting and Conference Rooms 4 2 HL3G 04 PPL1FOH9 Use a Filing System 4 3 HL3F 04 PPL1FOH10 Contribute to Solving Business Problems 6 3 HL1C 04 PPL2GEN4 Maintain Food Safety in a Kitchen Environment 5 5 HL2E 04 PPL1FBS1 Prepare and Clear Areas for Food and Beverage Service 4 3 HL2D 04 PPL1FBS2 Provide a Food and Beverage Service 5 4 HL22 04 PPL2FBS8 Prepare and Serve Dispensed and Instant Hot Drinks 5 3 Group C: four units required SQA Code P1st Code Unit Title SCQF Level SCQF Credits HK7J 04 PPL1GEN3 Maintain Customer Care 5 3 HL2Y 04 PPL1HK1 Collect Linen and Make Beds 3 3 HL2X 04 PPL1HK2 Clean Windows from the Inside 4 1 HL2W 04 PPL1HK3 Help to Service Toilets and Bathrooms 4 3 HL2V 04 PPL1HK4 Help to Clean and Maintain Furnished Areas 4 3 HL2R 04 PPL1HK5 Work Individually and Follow Reporting Procedures in a Cleaning Environment 4 2 HL3R 04 PPLFOH1 Process Information for the Reception Function 4 3 HL3P 04 PPL1FOH2 Assist in Handling Mail 4 2 HL3N 04 PPL1FOH3 Communicate Information in a Business Environment 5 4 HL3M 04 PPL1FOH4 Make and Receive Telephone Calls 4 3 HL3L 04 PPL1FOH5 Receive, Move and Store Customer and Organisation Property 4 2 HL3K 04 PPL1FOH6 Service Public Areas at Front of House 4 3 HL3J 04 PPL1FOH7 Collect and Deliver Items for Customers and Staff 5 3 HL3H 04 PPL1FOH8 Prepare, Service and Clear Meeting and Conference Rooms 4 2 HL3G 04 PPL1FOH9 Use a Filing System 4 3 HL3F 04 PPL1FOH10 Contribute to Solving Business Problems 6 3
“enable editing” and hit Enter to activate – after you have enabled editing you should be able to listen to the document Sign Out Open up a list of links (Caps Lock + F7) Use first-letter navigation to locate “sign out” (press “S”) Tab to the “activate link” button, Enter to activate Compiled by Nina Wibbenmeyer, M.Ed. Short-Term Programs, TSBVI wibbenmeyern@tsbvi.edu 512.206.9361
List of Entitlements [insert name of Venue Operator] Order specified for cl 5.4(a) Entitlement Number Geographic Area condition Venue condition 2022-2032 Price $ [insert] [insert] [insert] [insert] [insert] [insert] [insert] [insert] [insert] [insert] [insert] [insert] TOTAL [insert]
15. A can of paint in the shape of a cylinder has a radius of 4 inches and a height of 9 inches. Which formula is needed to find the volume of the can? 16. A right triangle is shown below. How long is x in inches? 17. The perimeter of the rectangle is 36 centimeters. What is the length of the diagonal? 18. Toni draws a scale map that shows the location of her home, her school, and the grocery store. If each square’s length representsof a mile, how far is it from home to her school?
26. What number isequivalent to? 27. The average distance from Earth to the Moon is approximately 238,855 miles. Which expression is the best estimate of this distance? 28. The population of the United States is approximatelypeople. The population of Germany is approximatelypeople. Which statement about the populations of these countries is true? 29. The diameter of a grain of sand is 0.06534 millimeter. Which value is the best estimate of this diameter? 30. An Olympic-size swimming pool holds approximatelygallons of water. The capacity of this swimming pool is between which interval? 31. The distance from Earth to the Sun is approximatelymiles. The distance from Earth to the moon is approximatelymiles. Approximately how many times the
distance from the Earth to the Moon is the distance from Earth to the Sun? 32. Which is equivalent to 1,800,000? 33. Scientists have identified approximately 250,000 existing species of flowering plants. Which expression represents 250,000 in scientific notation? 34. One cubic inch is equal to 0.000016387 cubic meters. In scientific notation, which of the following numbers best approximates the number 0.000016387? 35. Mars is about 47 million miles from Earth. Which expression shows this approximate distance in scientific notation? 36. The Sun has a diameter of approximately 1,390,000 kilometers. How is the approximate diameter of the Sun expressed in scientific notation? 37. Ifwhat is the value of n?
be more than one account. SUBAGREEMENT Subagreements Fully signed subagreement (with completed FFATA attachments) Fully signed modifications(s) when applicable For multiple-year sub awards, a folder for each year can be helpful to organize the agreements and related documents. Awarded Budget - Sub When applicable, revised versions of budget, SOW, contact information No Folder Correspondence with Subrecipient SEGMENT Invoicing Info Current: Final versions of invoices or financial reports submitted to sponsor Closeout documents such as final progress report, invention statement Fixed price residual balance form Master Reporting/Invoice Template if applicable Post FIRST Implementation April 2018: Documents will be uploaded to the Financial Reports Document Repository related to each Deliverable. Segment Homepage>Financial Reports>select financial deliverable>Documents For awards where multiple invoices per year are required, it may be helpful to create sub-folders by year. Any Related backup should be uploaded. Cost Transfers Cost Transfers (under 90 days) Over 90 Day Cost Transfer Folder may be created by departments for under 90 day cost transfers at departmental discretion. OSP Research Finance approving manager will upload all over 90 day cost transfer forms. Use description to clearly ID over or under 90 day FFATA Reports Issued FFATA Reports Folder may be created by OSP Senior Sponsored Programs Administrator where applicable. This
Tomball Memorial High School 1st Nine Weeks 2017-2018 Teacher: Kilcoyne August 22-October 14 Course: AP Calculus BC Monday Tuesday Wednesday Thursday Friday Aug 21 Staff Development No Students 22 Expectations, Procedures and Quick Review 23 2.1: Limits 24 2.1: Limits 25 2.2: Limits Involving Infinity 28 2.3: Continuity (Take Home Quiz) 29 2.3: Continuity 30 2.4: Rates of Change and Tangent Lines 31 Review Unit 2 Sept 1 UNIT 2 TEST 4 No School Labor Day 5 3.1: Derivative 6 3.1: Derivative 7 Senior Class Meeting 8 3.2: Differentiability (Take Home Quiz) 11 3.3: Rules of Differentiation 12 3.3: Rules of Differentiation 13 3.4: Velocity and Other Rates of Change 14 3.4: Velocity and Other Rates of Change 15 3.5: Derivatives of Trig Functions
18 3.5: Derivatives of Trig Functions 19 Quiz (Unit 3) 20 Review Unit 3 21 UNIT 3 TEST 22 4.1: Chain Rule 25 4.1: Chain Rule 26 4.2: Implicit Differentiation 27 4.2: Implicit Differentiation 28 4.3: Derivatives of Inverse Trig Functions 29 4.3: Derivatives of Inverse Trig Functions Oct 2 4.4: Derivatives of Exponential and Log Functions 3 Practice Unit 4 4 Review Unit 4 5 UNIT 4 TEST 6 5.1: Extreme Values of Functions (Half Day) 9 Staff Development 10 5.1: Extreme Values of Functions 11 Senior Picnic 12 5.2: Mean Value Theorem for Derivatives 13 5.3: Connecting f' and f'' with the Graph of f
Name ____________________ Date ________________ Which Function of Marketing does “it” relate to? (2 pts) What is it? What does it do? (3 pts) Where I saw it? (Specific location, be detailed) (3 pts) What is the Target Market? (Must include Demo, geo, Psycho) (5 pts) How Much Does it cost? (2 pts) Why I think it’s GREAT! What attracted you to it? (5 pts)
Rental income (from property or land) Maintenance agreements Separation/Divorce agreements Other income (please specify) PART 7 : Income from the Department of Social and Family Affairs (DSFA) Estimated total income for the year ended 31st December 2016 Father Mother Guardian DSFA – Unemployment benefit DSFA – Unemployment assistance (short term) DSFA – Unemployment assistance (long term) DSFA – One Parent Family payment DSFA – Pension Payment (please specify) DSFA – Family Income Supplement DSFA – Disability Benefit
Teaching Methods Interactive lectures (seminar), company visits including executive talks with representatives from selected German companies Assessment Method Presentations, research papers Recommended Reading Required reading: Porter, Michael: Competitive Strategy: Techniques for analyzing industries and competitors. – Free Press, 2004 Schwab, Klaus (ed.): The Global Competitiveness Report 2015-2016. – World Economic Forum, Geneva, 2015 (available online www3.weforum.org) Recommended reading: Badke, William: Research Strategies: Finding your way through the information fog. – 5. ed. – i-Universe, 2014 Blakeman, Karen: Search Strategies for the Internet. How to identify essential resources more effectively. – 6. Ed. RBA Information Services, 2006 Dicken, Peter: Global Shift. Mapping the Changing Contours of the World Economy. – 7 ed.- London: Sage Publ., 2014 Hedin, Hans; Hirvensalo, Irmeli; Vaarnas Markko: The Handbook of Market Intelligence: Understand, compete and grow in global markets. – 2. ed. – John Wiley & Sons, 2014 Kahaner, Larry: Competitive Intelligence: How to gather, analyze and use information to move your business to the top. – Touchstone, 1998 Simon, Hermann: Hidden Champions of the Twenty-First Century: The success strategies of unknown world market leaders. – Berlin: Springer, 2009 Statistisches Bundesamt (ed.): Data and publications. – (available online ) Latest articles on different German Industries in the international press e.g. The Economist, Financial Times, Businessweek Module Coordinator Prof. Ragna Seidler-de Alwis, MBA Lecturers Prof. Ragna Seidler-de Alwis, MBA Version 1
Course description Name of Module Business Environment: United States Course Code 224-10 1 Credit Points SWS Attendance (h) Self study (h) Total workload (h) 3 3 45 45 90 Semester Language 4 English Prerequisites Enrollment in the Global MBA Program or permission of the instructor. Intended Learning Outcome Upon successful completion of this course, the student will be able to: : Describe the general business environment in the United States. Compare and contrast the specific environments faced by several business and nonprofit organizations in the United States. Compare and contrast the factors that continue to influence diverse practices of business and nonprofit organizations in the United States. Describe the changing relative economic power of the United States and the implications for future business relationships. Describe his or her reflections on business and culture as experienced in the GlobalMBA program. Demonstrate the ability to research and analyze business and nonprofit organizations and present that research in a concise engaging format. Become familiar with business and nonprofit organizational practices in the United States by completing the STAR program offered by the Coggin College and participating in the GlobalMBA service project. Content In this course the core content is focused on the environments and practices of business firms and nonprofit organizations in the United States. The main activity of the course will be to compare and contrast the business environments and practices of firms located in the northeast section of Florida. Each student will develop a set of eight points of keen interest around which he/she will examine business materials obtained from (1) on line sources and visits to the firms’ physical operations and discussions with executives of these firms and (2) discussions with community representatives of business support organizations. Teaching Methods Interactive lectures (seminar), company visits including executive talks with representatives from selected German companies Assessment Method Papers, presentations, attendance, research reports, workshops. Recommended Reading Serwer, Andy (ed.) American Enterprise: A History of Business in America. Washington, D.C.: Smithsonian Institution, 2015. ISBN: 978-1-58834-496-0
WebPages for all “Business Visit” firms. Items provided in “Course Documents” on the blackboard (“Bb”) site for the course Module Coordinator Prof. Dr. Steven Paulson Lecturers Prof. Dr. Steven Paulson Version 1
GMLPC Service Summary Service: Emergency Hormonal Contraception Locality: Rochdale Commissioner: Rochdale Borough Council Service Key Contact Andrea Dutton, Commissioning Lead for Rochdale Council Remuneration All payments will be made on a quarterly basis, in arrears, on submission of claims made to Public Health Department, Rochdale Borough Council with appropriate supporting information. The Pharmacy will receive the following scheme of payments: £25 - Consultation with the client to advise on sexual health and taking the relevant history consistent with the protocol and PGD £5.95 - Pregnancy testing £5.20 -(Drug Tariff price plus VAT @ 5%) - Reimbursement of Levonorgestrel 1.5mg tablet The fee structure will be reviewed annually. Service Summary Pharmacists will supply Levonorgestrel Emergency Hormonal Contraception (EHC) when appropriate to clients in line with the requirements of the Patient Group Direction (PGD) (Appendix A). The supply will be made free of charge to the client at NHS expense. Claim Method/ Procedure All payments will be made on a quarterly basis, in arrears, on submission of claims made to Public Health Department, Rochdale Borough Council with appropriate supporting information Any Relevant PGDs: Yes Formulary for Service: Levonorgestrel 1.5g
Meeting Dates 2018 GMMMG/CSB Meetings Date Time Venue Thursday 8th February 2018 1pm – 3pm St James House Salford CCG Thursday 12th April 2018 1pm – 3pm St James House Salford CCG Thursday 14th June 2018 1pm – 3pm St James House Salford CCG Thursday 9th August 2018 1pm – 3pm St James House Salford CCG Thursday 11th October 2017 1pm – 3pm St James House Salford CCG Thursday 13th December 2017 1pm – 3pm St James House Salford CCG
2 Commissioning Process 3 3 Underpinning Principles 8 4 References 10 Appendices Appendix 1 Summary of the PbR Excluded Drug Request Process 11 Appendix 2 North West PCT Alliance Medicines and Treatments Group: description of exceptionality for funding panels 12 Appendix 3 PbR Excluded Drugs: GMMMG’s Advisory Position attached
This is a difficult area of PCT practice because of the frequent lack of clarity and the highly charged, emotive nature of the applications. We would urge all those involved in these processes to collaborate with commissioners, clinicians and legal advisors to establish common understanding of the principles and share best practice. _______________ NW PCT Medicines and Treatments Group 8th April 2009 Acknowledgements and thanks This guidance has been developed with the assistance of the following: Dr. Claire O’Donnell, Clinical Effectiveness Specialist in Public Health, North West Specialised Commissioning Team Dr. Sally Nelson, Consultant in Public Health, South Central Specialised Commissioning Team Dr Corinne Camilleri-Ferrante, Consultant in Public Health, Derbyshire PCT Dr Ash Paul, Medical Director, Bedfordshire PCT Dr Jonathan Howell, Consultant in Public Health, Specialised Commissioning Team Dr Daphne Austin, Consultant in Public Health, Specialised Commissioning Team Dr Mark Lambert, Consultant in Public Health, South of and Wear PCTs and Fellow of the NHS Institute of Innovation. Dr Nicholas Hicks, National Coordinating Centre for Health Technology Assessment Dr Gary Cook, Consultant Epidemiologist and Head of Clinical Effectiveness Unit, NHS Foundation Trust References 1Priority setting: an overview; Priority setting: managing new treatments; Priority setting: legal considerations 2008 NHS Confederation Publications. Available from www.nhsconfed.org/publications 2 Priority setting: managing individual funding requests. Available from www.nhsconfed.org/publications
The following drugs may be prescribed with caution: Antiepileptics Antihypertensives Benzodiazepines Opioids Alcohol Anticoagulants H2 receptor blockers or antacids - some MR preparations of methylphenidate must not be taken together with H2 receptor blockers or antacids 8. Adverse drug reactions For a comprehensive list (including rare and very rare adverse effects), or if significance of possible adverse event uncertain, consult Summary of Product Characteristics or BNF Specialist to detail below the action to be taken upon occurrence of a particular adverse event as appropriate. Most serious toxicity is seen with long-term use and may therefore present first to GPs. Adverse event System – symptom/sign Action to be taken Include whether drug should be stopped prior to contacting secondary care specialist By whom nausea, diarrhoea, abdominal cramps Continue treatment unless severe & Refer to Specialist Team GP Symptoms of depression, paranoia, psychosis, anxiety Continue treatment & urgently refer to Specialist Team GP palpitations, tachycardia, hypertension or hypotension Stop treatment & Refer to Specialist Team GP sleep disturbances, insomnia Continue treatment & Refer to Specialist Team GP seizures, convulsions Discontinue drug immediately. Send immediately to A&E GP/Specialist Team movement disorders, tics, tremors Continue treatment unless severe & Refer to Specialist Team GP anorexia, significant weight loss, growth retardation Continue treatment & Refer to Specialist Team GP The patient should be advised to report any of the following signs or symptoms to their GP without delay: Aggression, depression, paranoia, anxiety, suicidal thinking or self-harming behaviour Cardiac symptoms – racing pulse, increased heart rate, chest pain Uncontrollable muscle movements Abdominal pain, unexplained nausea, malaise, darkening of the urine or jaundice Other important co morbidities: ASD, Tourette syndrome, Depression, Anxiety Substance misuse: Potential misuse or diversion of stimulants must be minimised by careful selection of patients, prescribing of small amounts of medication and prompt discussion between
Significant weight loss, Anorexia Continue medication & Refer to usual Psychiatry Team GP Mania/hypomania Stop mediation & Refer to usual Psychiatry Team GP Cardiac arrhythmias (e.g. QT prolongation) Stop mediation & Refer to usual Psychiatry Team GP Rash and allergic reactions Stop mediation & Refer to usual Psychiatry Team GP Serotonin syndrome or neuroleptic malignant syndrome-like events Stop mediation & Refer to usual Psychiatry Team GP Restlessness or agitation Stop mediation & Refer to Specialist Team GP The patient should be advised to report any of the following signs or symptoms to their GP without delay: Restlessness or agitation, Suicidal behaviour, self-harm, or hostility Drowsiness, confusion, or convulsions Other important co morbidities (e.g. Chickenpox exposure). Include advice on management and prevention and who will be responsible for this in each case: ADHD, ASD, Tourette syndrome, Anxiety disorders Any adverse reaction to a black triangle drug or serious reaction to an established drug should be reported to the MHRA via the “Yellow Card” scheme. 9.Baseline investigations List of investigations / monitoring undertaken by secondary care The use of antidepressants has been linked with suicidal thoughts and behaviour; children, young adults, and patients with a history of suicidal behaviour are particularly at risk. Parents/ carers should be specifically warned about this risk, and this should be recorded in the notes. Where necessary patients should be monitored for suicidal behaviour, or hostility, particularly at the beginning of treatment or if the dose is changed. Specific arrangements must be made for careful monitoring of adverse drug reactions, as well as for reviewing mental state and general progress; for example, weekly contact with the child or young person and their parent(s) or carer(s) for the first 4 weeks of treatment. The precise frequency will need to be decided on an individual basis by secondary care, and recorded in the notes. 10. Ongoing monitoring requirements to be undertaken by GP Is monitoring required? No specific monitoring is required as specialist CAMHS services will continue to monitor for adverse drug reactions, mental state and general progress at appropriate intervals. 11. Pharmaceutical aspects No special considerations.
DUE DATE – January 16, 2015 The driving question: What is “big agriculture’s” relationship to GMOs (genetically modified organisms) and what should the general public know or do about this relationship? GMO RUBRIC Levels/ Criteria 1 2 3 4 Data, citations, and observations Data and observations are incorrect or missing entirely. Relevant citations are limited or missing. Citations and observations are incomplete or do not include pertain to the subject. Data, citations and observations are complete and correct. Data, citations, and observations are complete and correct. Student provides a level of detail and organization that goes above and beyond requirements. Conclusions, Explanations, and the driving questions Conclusions and explanations are missing or do not make sense given student's citations and observations. Makes little or no attempt to answer the driving question Conclusions and explanations are incomplete or not supported by sufficient details. Attempts to answer the driving questions but does so ineffectively Conclusions and explanations are complete and supported by student's data and citations. Relevant data and observations are referenced where appropriate. Driving question is answered. Conclusions and explanations are complete and supported by student's data. Student provides a level of detail and depth that goes above and beyond requirements. Driving question is answered completely with elaboration as to future issues. If you have read this rubric then you are probably prepared to do the research that is above and beyond what you have already accomplished in class for the GMO debate. In order to receive extra credit you will need to submit via email a complete analysis of the driving question that is between 1200 and 1500 words, You will also need to be prepared to answer various questions in front of the class so that you can help display your knowledge of this concept while educating your classmates. The extra credit you earn will be directed toward your lowest homework or project score. Using the rubric above: A paper that scores a 1 will earn 0 extra credit points, 2 will earn 5 points, 3 will earn 10 points, a 4 will earn up to 20 extra credit points. Those who earn 4 points will be asked to present their ideas to the class and answer a few questions.
DNA transfers into the DNA of organisms in the human stomach, reproducing indefinitely and causing a number of gastrointestinal issues (Benson, 2013). Effects of GMOs on the Environment The largest affect of GMOs on our environment is the declining bee population. Bees are extremely important to the human ecosystem, fertilizing 80% of flowering crops. While this may seem to only effect produce, the affect of honeybees reaches much further, threatening the dairy and beef industries is alfalfa is not pollinated and available for livestock feed (Boland, 2010). GMOs have been found to be largely responsible for the decline in the bee population in two major ways. First, the Bt protein in GMO crops causes the stomach of insects, such as bees, to implode, thus killing entire hives of bees. This decline in the bee population has affected entire ecosystems, and threatens to endanger the lives of humans. Since commercial beehives pollinate 1/3 of America’s crops, the people of the world rely on these insects to keep the farming industry strong (Boland, 2010). The second major cause of bee health issues due to GMOs is the increased use of pesticides because of GM plants. While some genetically modified organisms produce their own pesticides, others are modified to form a resistance to pesticides. Because of this, farmers often use pesticides more liberally around GM crops, thus increasing the amount of pesticides in the surrounding environment (Dill, 2010). Since GMOs were introduced, pesticide use has increased by over 527 million pounds (Benson, 2013). Another affect of GMOs on the insect population is infertility. Many genetically modified plants are created to purposefully produce infertile seeds that farmers cannot replant, therefore creating the need for farmers to purchase more of the
Retrieved from Fedoroff, N. (1999). Mendel in the Kitchen. Washington DC: Joseph Henry Press. Group, F. E. (2006). Genetically Modified Foods. Global Healing Center, Retrieved from (2011). Genetcally Modified Food Explained. Australian Government, Retrieved from Hart, K. (2002). Eating in the Dark. New York: Pantheon Books. Hartl, J. (2001). Genetically Modified Food to Fight Hunger. The Hungry World, Retrieved from Herda, D. J. (1990). Land and Abuse. New York, London, Sydney: Library of Congress. Lappe, A. (2010). Diet for a Hot Planet. New York: Bloomsbury. Mc Gonvern, G. (2001). The Third Freedom. New York: Simon & Schuster. Mc Hughen, A. (2000). Pandora's Picnic Basket. New York: Oxford Press. Nestle, M. (2003). Safe Food. California: California Press. Pringle, P. (2003). Food inc.. New York: Simon&Schuster. Pawlikc, T. (2006). The End of Food. New Jersey: Barricade Books Inc. Richards, B. (2010). Health Scandal. News With Views, Retrieved from Roberts, P. (2008). The End of Food. Boston, New York: Houghton Mifflin Company.
water troughs where the flock would come to drink, in front of the flock. Now they would be in heat as they came to drink; thus the flock came to be in heat by the rods, and the flock bore streaked, specked, and dappled young. Source #5: Bereshit Rabbati, Vayetze (p. 129) אל היה היה אלא That you have made them little less than divine—This refers to Jacob, for it says (in Genesis 30:39), and since the goats mated by the rods…. Rabbi Hoshaya explains, “He would draw an image, and just as he drew, so the seed formed in the water of their wombs, and so did they give birth. This teaches that [Jacob] lacked only the ability to give them a soul.” Rabbinic Source: Establishing Guidelines for Kilayim Source #6: Talmud Yerushalmi, Tractate Kilayim 1:1 (Venice ed., 27a) How do we know that one may not graft a barren tree onto a fruit tree, nor a fruit tree onto a fruit tree of a different species? Because it [the Torah] states: Guard my statutes. R’ Yonah [quotes] R’ ‘Lazar in the name of Kahana: It is in accord with R. ‘Lazar’s saying—“the statutes—are those that I have established in My world.” Henceforth it is forbidden [to blend species] since Adam the First. R’ Yosi in the name of Rabbi Hila [says], all agree that [the prohibition derives from the word] “statutes” that I have established in my world. Henceforth it is forbidden to graft a black fig [tree] onto a white fig [tree]. The Post-Rabbinic Debate Source #7: Sefer HaHinukh (anonymous, 13th c., Barcelona), #545, Sending off the mother bird…: God created the species to persist. וגו', לא ה' אלו
Name: _________________________ Genetically Modified Organisms Introduction: This assignment will explore two of the main uses for genetic modification of organisms: 1) Increasing our food supply and enhancing the nutritional value to ensure that the basic requirements of all individuals worldwide can be sustained. 2) Improving the health and quality of life, as well as decreasing the incidence of disease, with the development of pharmaceutical medicines, vaccines, and a healthier diet. Even though there are obvious benefits for humans from these scientific developments, many people will still argue that the long-term effects outweigh any benefits. By the time you have completed this assignment, you will be able to make a more informed decision and form your own opinion based on the information provided from several different sources. Part 1: What are Genetically Modified Organisms (GMOs)? Copy and paste the following website into your browser. Read the article and answer the questions below. 1) How is biotechnology different from genetic modification? 2) What is the purpose of recombinant DNA technology? For 3-5, use the following link () 3) Which countries were responsible for growing the most biotech crops in 2012? How many hectares were devoted to these crops? Country Percentage 4) What types of crops made up the majority of these GM crops? 5) Identify 3 ways biotech crops have contributed to sustainability? a) b) c)
Experience K Alchian A Dowling W Free B Graham P Marshall J Montgomery T Rowland L Rudd R Warren I Wheatley L White S Williams A Wozniak Manufacturing Experience Immunobiologicals Sterile Non-sterile Ectoparasiticides Premix/Supplements Laboratory Practical experience (see legend below) a,b,c,d e, f a,b,c, e,f f a,b,c,d, e a,b,c, d,f a,b,c, d,f a,b,c, d, e, f a,b,c,d, e, f a,b,c, d,f a,b,c, d,f Quality Experience TGA compliance NATA compliance FDA compliance EU / PIC/s compliance NZMAF (ACVM) ISO compliance Educational qualifications Microbiology Chemistry Pharmacy Biochemistry Audits Available to conduct interstate audits in Australia Available to conduct overseas audits Practical experience legend: (a) short run, multifaceted operations, (b) long run dedicated equipment, (c) small company experience, (d) large company experience, (e) veterinary manufacturing experience, and (f) veterinary manufacturing experience as a consultant.
Table 1: Deployment, Installation, Back-out, and Rollback Roles and Responsibilities ID Team Phase / Role Tasks Project Phase (See Schedule) Site personnel in conjunction with IT support – which may be local or ITOPS. Deployment Plan and schedule deployment (including orchestration with vendors) After national release. Site personnel in conjunction with IT support – which may be local or ITOPS. Deployment Determine and document the roles and responsibilities of those involved in the deployment. After national release. Site personnel. Deployment Test for operational readiness After national release. Site personnel in conjunction with IT support – which may be local or ITOPS. The IT support will need to include person(s) to install the KIDS build as well as the personnel to deploy the GUI – which may be done on each machine, a shared network and/or the Citrix access gateway Deployment Execute deployment After national release. Site personnel in conjunction with IT support – which may be local or ITOPS. The IT support will need to include person(s) to install the KIDS build as well as the personnel to deploy the GUI – which may be done on each machine, a shared network and/or the Citrix access gateway Installation Plan and schedule installation After national release. N/A – will work under the VistA ATO and security protocols. Installation Ensure authority to operate and that certificate authority security documentation is in place
N/A – no equipment is being added. Installation Validate through facility POC to ensure that IT equipment has been accepted using asset inventory processes Local support personnel or CACs. Installations Coordinate training Facility CIO and IT support – which may be local or regional. Back-out Confirm availability of back-out instructions and back-out strategy (what are the criteria that trigger a back-out) After national release. Hardware and System support – no changes. Software support will be the CPRS Development Team during the compliance period. At the end of the compliance period, support will be transitioned to HPS Clinical Sustainment. Post Deployment Hardware, Software and System Support After national release. Deployment The Problem Selection List Enhancements will have a standard release with a 30-day compliance window. This patch will be released as part of a combined multi-package build under PROBLEM SELECTION LIST BUILD 1.0. This combined build consists of the GMPL*2.0*49 and OR*3.0*429 patches. There are currently no site-facing on-line meetings or training planned for this deployment. Timeline The provisional timeline calls for the patch to be released sometime in the summer or fall of 2017 with a 30-day compliance period after national release. Site Readiness Assessment This section discusses the locations that will receive the Problem Selection List Enhancements deployment.
Grey Mountain Primary School Goal Setting Conference Student Name: Grade: Teacher: Date of Conference: In Attendance: Learning Area Learning Goal (student voice) What it Looks Like in My Classroom and at School What I Need to Help Me as I Work Toward my Goal Literacy Kids print/type here or you scribe … I will be able to … Teacher: Family: Self: Numeracy Kids print/type here or you scribe … I will be able to … Teacher: Family: Self: Core Competencies Kids print/type here or you scribe … I will be able to … Teacher: Family: Self:
Section A. MANUFACTURER & AUDIT DETAILS Street address of manufacturer Details of any additional premises audited Audit Owner (overseas audits only) Date/s of audit Type of audit FULL – Initial FULL - Subsequent Extension of licence scope (please provide details) Auditor/s Duration of audit (hours) (inspection/ assessment time) Categories of manufacture covered in audit Report Attached Annex 1 2 3 4 5 6 (please delete as appropriate) Names and positions of key people interviewed Person actually in charge of Production Person actually in charge of Quality Are the details of the current APVMA licence (ie. company details and product scope) correct for this manufacturer? If not, please provide comment Was the full, current APVMA licence on public display at the premises? YES NO – provide comment Aspects of Code of GMP NOT covered at this audit (if any) (please include reason/s)
DATE OF AUDIT Notification of Completed Audit sent to APVMA (Auditor) 24 hrs for CRITICAL NCs Audit Report & associated documents sent to Manufacturer & APVMA (Auditor) Audit Report & Response sent to APVMA (copy Response to Auditor with evidence) (Manufacturer) Statutory Declaration submitted to APVMA confirming all NCs addressed as per approved plan (Manufacturer) Confirmation NCs addressed or satisfactory plan approved – Final advice sent to APVMA (Auditor)
Transaction cancelled for balance of service term Operational GTA may give shipper the option to continue use for the balance of the service terms at a capacity charge negotiated in advance or at the time Notified D+30 to D+54, notification rejected, seller delivery default Operational GTA may give shipper the option to continue use for the balance of the service term at a capacity charge negotiated in advance or at the time Monthly firm forward haul D-2 D to D+30 Notified D-2 and MDQ transferred Secondary shipper uses capacity since service term falls in the period ending D+30 Notified D-1 to D+29 and MDQ transferred Secondary shipper uses capacity on D to D+30 since service term is within the period ending D+30 Weekly firm forward haul D-2 D+7 to D+14 Notified D-2 and MDQ transferred Secondary shipper uses capacity Notified D+6 to D+14 and MDQ transferred Secondary shipper uses capacity Daily firm forward haul D-2 D+3 Notified D-2 and MDQ transferred Secondary shipper uses capacity Notified D-1 and MDQ transferred Secondary shipper uses capacity
Subdivision 5.7 of Part 18 applies and capacity transaction reporting is mandatory from this date (except for transactions for capacity on an NT facility, if the interconnector commissioning date is after the Part 24 commencement date) Schedule 5, Part 2, rule 2(1) First day from which an auction facility operator must keep and maintain nomination and scheduling records Schedule 5, Part 4, rule 4(1) Part 25, rule 665(1) First day from which transportation facility user for an auction facility must keep renomination records Schedule 5, Part 4, rule 5(1) Part 25, rule 666(1) 2 March 2019 First day for use of auctioned capacity Follows from day-ahead nature of auction First day for use of transportation capacity purchased through the GSH Follows from day-ahead nature of product 1 April 2019 AEMO must publish information about the arrangements for transition to the standard market timetable Schedule 5, Part 6, rule 3 30 June 2019 Facility operator for a natural gas facility must publish information about its arrangements for the transition to the standard market timetable Schedule 5, Part 6, rule 4 1 October 2019 Standard market timetable comes into effect Schedule 5, Part 6, definition of ‘Part 26 transition date’ and rule 2 First anniversary of initial Rules start date First day for Code modifications to come into effect (unless urgent or minor) Schedule 5, Part 3, rule 2 1 March 2021 Grandfathering of rights for the purposes of the capacity auction ceases at 6:00 am Schedule 5, Part 4, rule 1 definition of ‘protected rights transition period’
Table .: Key timing for initial Part 24 facilities and allocation agents (including facilities that will apply for an exemption) Date Activity Reference Rules start date on or before 1 December 2018 Trigger date for being an initial Part 24 facility Will include NT facilities if the commissioning date for the NT interconnector is on or before the rules start date Schedule 5, Part 3, rule 5 Trigger date for being an existing BB allocation agent and existing BB allocation point Schedule 5, Part 2, rule 3 Rules start date + 20 business days Last date for the transportation service provider for an initial Part 24 facility (if not the subject of a transitional exemption) to apply to register under Part 24 Schedule 5, Part 3, rule 5 Part 24, rule 618 Last date to apply to register an initial Part 24 facility under Part 24 (if not the subject of a transitional exemption) Schedule 5, Part 3, rule 4 Part 24, rule 619 Last date for existing BB allocation agent to apply to register under Part 24 Schedule 5, Part 2, rule 3 Part 18 rule 158A Last date to apply to register an existing BB allocation point under Part 24 Schedule 5, Part 2, rule 3 Part 18 rule 158B Rules start date + 40 business days Obligation to publish operational agreement Part 24, rule 631(1) 1 March 2019 Existing auction facility becomes subject to the capacity auction Schedule 5, Part 4, rule 2 Schedule 5, Part 4, definition of ‘capacity auction start date’
Table 3.2: Project teams’ evaluation of the capacity trading platform(s) options Evaluation criteria AEMO Operated Platform Pipeline Operated Platform(s) Single Platform Multiple Platforms Operation of platform: Operated by independent and experienced operator Could be independent if a Joint Venture is established Operated in a predictable and reliable manner Untested but expected to be operated in this manner Untested but expected to be operated in this manner Operation of platform underpinned by a robust governance framework (Already established in NGL, NGR and Exchange Agreement) Would need to be established Would need to be established Transparency in costs and operation of platform Could be mandated Could be mandated Could be mandated Trading System Features: Provides for low transaction costs and quick and effective execution of trades (while transaction costs were considered relatively low, some concerns were raised about the barrier the annual licence fee may pose to small players) Untested Untested Integrated with pipeline operators’ nominations and scheduling processes Separate processes required Separate processes required Separate processes required Co-ordination benefits: Shippers can readily co-ordinate trades across pipelines Shippers can readily co-ordinate trades with other services on the GSH Scale and scope benefits and adaptability: Capable of capturing scale and scope benefits (e.g. new capacity and other gas services can be added over time and shippers can aggregate prudential requirements across the GSH) Potentially but not to the same extent as the AEMO operated platform Potentially but not to the same extent as the AEMO operated platform Future proof, scalable and adaptable Potentially Potentially Implementation Costs: Est. $90,000-$140,000 No estimate provided but expected to be higher than the AEMO option because new exchange trading platform and matching algorithm, settlement, prudential, reporting systems and legal arrangements wold need to be put in place The feedback that project team members provided on this issue is consistent with the feedback that most stakeholders expressed during the AEMC’s East Coast Review, which
Name Course PhD in related field At least 2 PRJ and 3 PR other contributions in last 5 years Exception: PhD in Progress (3 years of ABD or enrolled in course work) Exception: PhD in last 5 years Supporting Data Taught for the department for more than 3 semesters Professionally Qualified Candidates: Name Course Master’s or higher in related field Significant, non-teaching activity in past 5 years (check at least two): Supporting Data Taught for the department for more than 3 semesters (A) Practice (B) Consulting (C) Professional Development (D) Other Professional Activities Updated: Month Day, Year CURRICULUM VITAE: ACADEMIC NAME: Last Name, First Name RANK: (Instructor, Assistant Professor, Associate Professor, or Professor) DEGREES Degree Type Educational Institute, Year
If you are returning from the Armed Forces: Address before enlisting: Service or Personnel Number: Enlistment date: If you are registering a child under 5 I wish the child above to be registered with the doctor named overleaf for Child Health Surveillance Yes No If you need your doctor to dispense medicines and appliances (Note: not all doctors are authorised to dispense medicines.) I live more than 1 mile in a straight line from the nearest chemist.
The Pharmacological Basis of Therapeutics. Laurence Brunton. Goodman & Gilman's 12th ed. McGraw-Hill Professional; 10 edition 2011 . ISBN: 978-0071354691 Prerequisite Knowledge and Skills: You are expected to be familiar with basic Neuroscience concepts before starting this course series. If you are uncertain about the sufficiency of your background, you are encouraged to read through chapters one through ten in Neuroscience Online – an electronic textbook (Open Access) Day Date Topic Lecturer 1 Mar 24 Introduction to Neuropharmacology. History of Drug Discovery Past to Present Dr. Habibeh Khoshbouei Pharmacogenomics Dr. Eduardo Candelario-Jalil 2 Mar 26 Principles of Nervous System Physiology & Pharmacology Site of Action of Drugs & Signal Transduction Mechanisms Dr. Eduardo Candelario-Jalil 3 Mar 28 Theoretical and practical analysis of Receptor Occupancy and Cellular Response Theoretical and practical analysis of Receptor Occupancy and Cellular Response Dr. Joanna Peris 4 Mar 31 Glutamatergic Neurotransmission Pathophysiology & Pharmacology of Glutamatergic Neurotransmsission Dr. Eduardo Candelario-Jalil 5 Apr 2 GABA & Glycine Neurotransmission Pathophysiology & Pharmacology of GABAergic & glycinergic Neurotransmission Dr. Eduardo Candelario-Jalil 6 Apr 4 Neuropharmacology of Acetylcholine – General Aspects Drugs Acting on Muscarinic Receptors Dr. Eduardo Candelario-Jalil 7 Apr 7 Neurophysiology of Nicotinic Acetylcholine Receptor System Nicotinic Acetylcholine Receptor System (Neuropharmacology) Dr. Roger Papke 8 Apr 9 Neurophysiology of the Dopaminergic System & Its Pathology Dopaminergic Receptor System. Therapeutic Approaches (Neuropharmacology) Dr. Habibeh Khoshbouei 9 Apr 11 MIDTERM EXAM Material thru Apr 9th 10 Apr 14 Neurophysiology & Pathology of the Adrenergic System Adrenergic System Neuropharmacology Dr. Joanna Peris
Gallup Main Street, Arts, and Cultural District 205 West Coal Avenue Gallup, NM 87301 (505)722-4430 Position(s) Applying For: Today's Date Name Social Security # Street Address City State Zip Phone(s) Email Emergency Contact Name Phone Are you currently employed? No Yes If yes, may we inquire of your present employer? No Yes Are you legally eligible for employment in the U.S: No Yes If necessary for the job, are you over (please mark one): 16 18 21 Please list your last three jobs, beginning with you most recently held job. Please explain any gaps in employment on a separate sheet ofoaoer Employer Supervisor Phone Street Address City State Zip Title Dates of Employment Job Duties Reason for Leaving Employer Supervisor Phone Street Address City State Zip Title Dates of Employment Job Duties Reason for Leaving Employer Supervisor Phone Street Address City State Zip Title Dates of Employment Job Duties Reason for Leaving
‘Rutherford’ & ‘Bedroom Tax.’ Sangeeta Enright, Fibrosis Trust Tom Royston, Garden Court Chambers North ‘Rutherford’ & Bedroom Tax’ Discussion about the Rutherford ‘Bedroom Tax’ case taken to the Supreme Court; Sangeeta Enright, formerly caseworker at Ridley and Hall, and Tom Royston, Garden Court Chambers. Paul and Susan Rutherford, who care for their severely disabled grandson, in a specially adapted three-bedroom bungalow in Pembrokeshire - which the bedroom tax decision deemed a spare room at 2
13. Is this rotation: Internal (within this LEP) External Both 14. If this post rotates externally please give the name of the training location/s with which it rotates: 1. 2. 3. 15. Please indicate the shift practice for this post: Full Shift Partial Shift On-call Rota Hybrid Other (please state) __________________________________ 16. Please state the staffing numbers for the specialty or sub-specialty programme at the training location(s) where this post is based: Consultants: Foundation Year: Specialist Registrars: Others (specify): 17. Please indicate the responsibilities of this post: Ward rounds per week: OP clinics per week: Average number of beds: Duty rota: 18. This question is to be completed in relation to General Practice Programmes only: Please provide details of the intended learning outcomes of the post (which must relate directly to the relevant sections of the General Practice curriculum): 19. Please provide a timetable of service and educational commitments (this may be attached): 20. What are the arrangements for the educational and clinical supervision in this post (these may be the same individual), and who are the named trainers? 21. This question is to be completed in relation to General Practice Programmes only: What arrangements are in place for access to the GP training release scheme? 22. What arrangements are there to participate in out-of-hours care?
3 4 5 Part 2 Rights of Access by Declaration [Section 234(5)] COLUMN 1 Name of landowner declaring right of access COLUMN 2 Description of land over which access is declared COLUMN 3 Name of access holders receiving rights of access COLUMN 4 Description of land receiving rights of access (Vol / Fol) (Vol / Fol) THIRD SCHEDULE
A. Household Size & Income Total Household Size ________ *Total Income $_________/______ ($ Amount) (Time Period) B. Benefits/Foster FoodShare WI W-2 Cash Assistance FDPIR Foster Child(ren) Free Reduced Non-Needy ______________________ **Effective Month of Determination ____________________________ Month/Year Weekly x 52 Twice a month x 24 Every 2 weeks x 26 Monthly x 12 *Convert to yearly income only when multiple pay frequencies are reported, using only these multipliers: